Literature DB >> 6305014

Glycosylation pathways of two major Epstein-Barr virus membrane antigens.

B C Strnad, M R Adams, H Rabin.   

Abstract

Monoclonal antibodies to the Epstein-Barr virus (EBV) membrane antigens (MA) were used to delineate the sequence of events occurring during MA maturation. Immunoprecipitation experiments performed with B95-8 virus infected 1605L cells, pulse labeled in the presence of tunicamycin or 2-deoxyglucose, suggest that the nonglycosylated forms of the mature 236,000 (236K) and 86K MA have molecular weights of 149K and 69K, respectively. Monensin treatment results in the accumulation of a 189K antigen which is converted to the mature 236K MA after a 2 hr chase in the absence of monensin. Experiments with monensin also suggest that an 84K intermediate is involved in the formation of the mature 86K MA. The mature 236K MA is resistant to endoglycosidase H while the 189K intermediate and the mature 86K MA are partially sensitive to this enzyme. The mature 236K and 86K MA and the 189K intermediate are resistant to endoglycosidase D.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6305014     DOI: 10.1016/0042-6822(83)90381-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

Review 1.  Epstein-Barr virus tissue tropism: a major determinant of immunopathogenesis.

Authors:  L Hutt-Fletcher
Journal:  Springer Semin Immunopathol       Date:  1991

2.  Localization of Epstein-Barr virus envelope glycoproteins on the inner nuclear membrane of virus-producing cells.

Authors:  M R Torrisi; M Cirone; A Pavan; C Zompetta; G Barile; L Frati; A Faggioni
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Expression of the Epstein-Barr virus gp350/220 gene in rodent and primate cells.

Authors:  Y Whang; M Silberklang; A Morgan; S Munshi; A B Lenny; R W Ellis; E Kieff
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

4.  Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB.

Authors:  M Gong; T Ooka; T Matsuo; E Kieff
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

5.  Demonstration of three major species of pseudorabies virus glycoproteins and identification of a disulfide-linked glycoprotein complex.

Authors:  N Lukàcs; H J Thiel; T C Mettenleiter; H J Rziha
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

6.  Induction of antibodies to the Epstein-Barr virus glycoprotein gp85 with a synthetic peptide corresponding to a sequence in the BXLF2 open reading frame.

Authors:  D E Oba; L M Hutt-Fletcher
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

7.  Identification of the Epstein-Barr virus gp85 gene.

Authors:  T Heineman; M Gong; J Sample; E Kieff
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

8.  An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200).

Authors:  M Hummel; D Thorley-Lawson; E Kieff
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

9.  Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene.

Authors:  C Beisel; J Tanner; T Matsuo; D Thorley-Lawson; F Kezdy; E Kieff
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

10.  Epstein-Barr viruses that express a CD21 antibody provide evidence that gp350's functions extend beyond B-cell surface binding.

Authors:  Clemens Busse; Regina Feederle; Martina Schnölzer; Uta Behrends; Josef Mautner; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.